Hansen AR, Gomez-Roca CA, Robbrecht DGJ, Verlingue L, et al. Phase 1b Study of the Immunocytokine Simlukafusp alfa (FAP-IL2v), in Combination with Cetuximab in Patients with Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 2024 Oct 18. doi: 10.1158/1078-0432.CCR-24-1562.
PMID: 39422604